Primary Progressive Multiple Sclerosis

Nonfiction, Health & Well Being, Medical, Allied Health Services, Radiological & Ultrasound, Specialties, Internal Medicine, Neurology
Cover of the book Primary Progressive Multiple Sclerosis by , Springer Milan
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9788847022348
Publisher: Springer Milan Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9788847022348
Publisher: Springer Milan
Publication: December 6, 2012
Imprint: Springer
Language: English

"Why are there no effective treatments for my condition? Why do researchers exclude patients with primary progressive multiple sclerosis from enrolling in clinical trials? Please let me know if you hear of studies that I might be allowed to enter or treatments that I could try for my condition. " Thus, in recent years, the sad lament of the patient with primary progressive MS (PPMS). This variant, often in the guise of a chronic progressive myelopathy or, less commonly, progressive cerebellar or bulbar dysfunction, usually responds poorly to corticosteroids and rarely seems to benefit to a significant degree from intensive immunosuppressive treatments. In recent years, most randomized clin­ ical trials have excluded PPMS patients on two counts. Clinical worsening devel­ ops slowly in PPMS and may not be recognized during the course of a 2-or 3-year trial even in untreated control patients. This factor alone adds to the potential for a type 2 error or, at the very least, inflates the sample size and duration of the trial. In addition, there is mounting evidence that progressive axonal degeneration and neuronal loss (rather than active, recurrent inflammation) may be important components of the pathology in this form of the disease. Although contemporary trials are evaluating whether PPMS patients may benefit from treatment with the ~-interferons and glatiramer acetate, preliminary, uncontrolled clinical experi­ ence suggests that the results may not be dramatic.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

"Why are there no effective treatments for my condition? Why do researchers exclude patients with primary progressive multiple sclerosis from enrolling in clinical trials? Please let me know if you hear of studies that I might be allowed to enter or treatments that I could try for my condition. " Thus, in recent years, the sad lament of the patient with primary progressive MS (PPMS). This variant, often in the guise of a chronic progressive myelopathy or, less commonly, progressive cerebellar or bulbar dysfunction, usually responds poorly to corticosteroids and rarely seems to benefit to a significant degree from intensive immunosuppressive treatments. In recent years, most randomized clin­ ical trials have excluded PPMS patients on two counts. Clinical worsening devel­ ops slowly in PPMS and may not be recognized during the course of a 2-or 3-year trial even in untreated control patients. This factor alone adds to the potential for a type 2 error or, at the very least, inflates the sample size and duration of the trial. In addition, there is mounting evidence that progressive axonal degeneration and neuronal loss (rather than active, recurrent inflammation) may be important components of the pathology in this form of the disease. Although contemporary trials are evaluating whether PPMS patients may benefit from treatment with the ~-interferons and glatiramer acetate, preliminary, uncontrolled clinical experi­ ence suggests that the results may not be dramatic.

More books from Springer Milan

Cover of the book Hematologic Problems in the Critically Ill by
Cover of the book The Role of Laparoscopy in Emergency Abdominal Surgery by
Cover of the book Brain Tumors by
Cover of the book Regional Anaesthesia Analgesia and Pain Management by
Cover of the book The Basic Principles of External Skeletal Fixation Using the Ilizarov and Other Devices by
Cover of the book Normal-appearing White and Grey Matter Damage in Multiple Sclerosis by
Cover of the book Ultrasound-guided Musculoskeletal Procedures by
Cover of the book The Tricuspid Valve in Congenital Heart Disease by
Cover of the book Minimally Invasive Surgery of the Pancreas by
Cover of the book Spectral Theory and Quantum Mechanics by
Cover of the book Knee Ligament Injuries by
Cover of the book Basic Technical Analysis of Financial Markets by
Cover of the book Trauma Surgery by
Cover of the book Fracture-Dislocations of the Wrist by
Cover of the book Mid-sized Manufacturing Companies: The New Driver of Italian Competitiveness by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy